Post-transcriptional regulation of endothelial cell plasminogen activator inhibitor-1 expression during R. rickettsii infection

Microbial Pathogenesis

Volumn 28, Issue 3, 2000, Pages 127-133

  Shi, Rui Jin ^a   Simpson Haidaris, Patricia J ^a   Marder, Victor J ^a   Silverman, David J ^b   Sporn, Lee Ann ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Plasminogen activator inhibitor 1; Rickettsia rickettsii

Indexed keywords

ACTIN; CYCLOHEXIMIDE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN SYNTHESIS INHIBITOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS INHIBITION; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; STEADY STATE; TRANSCRIPTION REGULATION;

ANIMALIA; EUKARYOTA; RICKETTSIA; RICKETTSIA RICKETTSII; RICKETTSIA RICKETTSSI; RICKETTSIALES;

EID: 0033821776     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1999.0333     Document Type: Article

References (39)

1. E-selectin-dependent neutrophil adhesion to Rickettsia rickettsii-infected endothelial cells
2. Interleukin-1 alpha production during Rickettsia rickettsii infection of cultured endothelial cells: Potential role in autocrine cell stimulation
3. Rickettsia rickettsii infection of cultured human endothelial cells induces tissue factor expression
4. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway
5. Von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells
6. Transcriptional regulation of endothelial cell tissue factor expression during Rickettsia rickettsii infection: Involvement of the transcription factor NF-kappaB
7. Increased expression of plasminogen activator inhibitor-1 in R. rickettsii-infected endothelial cells
8. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells
9. Type 1 plasminogen activator inhibitor
10. Plasminogen activator inhibitor-1: A common denominator in cardiovascular disease
11. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders
12. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells
13. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta
14. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells
15. Regulation of the fibrinolytic system of cultured human-vascular endothelium by interleukin 1
16. Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells
17. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor
18. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells
19. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation
20. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells
21. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: Modulation by thrombin, endotoxin, and histamine
22. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor
23. Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells
24. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester
25. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells
26. Inhibitors of translation
27. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha
28. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1
29. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, inter-leukin 1, and urokinase genes, which are controlled by short-lived repressors
30. c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages
31. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis
32. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation
33. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation
34. Human vascular endothelial cells in culture. Growth and DNA synthesis
35. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells
36. Potential for free radical-induced lipid peroxidation as a cause of endothelial cell injury in Rocky Mountain spotted fever
37. Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor
38. Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed
39. An improved method for mRNA isolation and characterization of in vitro translation products by Western blotting